TMC-2A, -2B and -2C, Novel Dipeptidyl Peptidase IV Inhibitors Produced by Aspergillus oryzae A374. I.Taxonomy of Producing Strains, Fermentation, and Biochemical Properties.

NOBUAKI NONAKA, Yasuyuki Asai, MAKI NISHIO, Kohei Takahashi, Tôru Okuda, Sumiko Tanaka, Takahisa Sugita, Tetsuo Ohnuki, Saburo Komatsubara

The Journal of Antibiotics · 1997 · 18 citations · 27 references

DOIFull text

Open access

Concepts

Abstract

TMC-2A(1), -2B (2) and -2C (3), novel dipeptidyl peptidase IV (DPIV) inhibitors, were isolated from the fermentation broth of Aspergillus oryzae A374. TMC-2A, -2B and -2C inhibited rat kidney DPIV with IC50 value of 8.1 microM, 17 microM, and 20 microM, respectively, as well as human DPIV prepared from mononuclear cells and adenocarcinoma cells. TMC-2 compounds inhibited only DPIV among the proteases tested, indicating their high selectivity for DPIV. The kinetic analyses revealed that TMC-2A was an uncompetitive inhibitor. Taxonomy and fermentation of the producing strain are also described.

References

27